<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, July 3, 2019 (HealthDay News) — For concussed athletes, interleukin (IL)-6 and IL-1 receptor antagonist (IL-1RA) are significantly elevated at six hours after concussion, and IL-6 levels are associated with symptom duration, according to a study published online July 3 in Neurology<\/i>.<\/p>\n
Morgan E. Nitta, from Marquette University in Milwaukee, Wisconsin, and colleagues examined whether acute elevations in serum inflammatory markers predict symptom recovery after sports-related concussion in a cohort of 41 concussed athletes and 43 matched control athletes. At a preinjury baseline, six, and 24 to 48 hours postinjury, and about eight, 15, and 45 days after concussion, serum levels of IL-6, IL-1\u03b2, IL-10, tumor necrosis factor, C-reactive protein, interferon-\u03b3, and IL-1RA were measured.<\/p>\n
The researchers found that compared with controls, and relative to preinjury and other postinjury visits, IL-6 and IL-1RA were significantly elevated in concussed athletes at six hours. At six hours postconcussion, IL-6 and IL-1RA significantly discriminated concussed from control athletes (area under receiver operating characteristic curve, 0.79 and 0.79 for IL-6 and IL-1RA, respectively). There was a significant correlation for IL-6 levels at six-hours postconcussion with symptom duration (hazard ratio for symptom recovery, 0.61).<\/p>\n
“These findings highlight the IL-6 and IL-1 pathways as possible targets for treatment development, consistent with recent attempts to determine the efficacy of recombinant human IL-1RA as treatment for severe traumatic brain injury in humans,” the authors write.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n